User profiles for Emmanuel Roilides

Emmanuel Roilides

3rd Department of Paediatrics, School of Medicine, Aristotle University of Thessaloniki
Verified email at auth.gr
Cited by 37743

Epidemiology and clinical manifestations of mucormycosis

…, A Skiada, O Lortholary, E Roilides… - Clinical Infectious …, 2012 - academic.oup.com
Mucormycosis is an emerging angioinvasive infection caused by the ubiquitous filamentous
fungi of the Mucorales order of the class of Zygomycetes. Mucormycosis has emerged as the …

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the …

…, A Patel, Z Racil, M Richardson, E Roilides… - The Lancet infectious …, 2019 - thelancet.com
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical …

Infections Caused by Scedosporium spp

KJ Cortez, E Roilides, F Quiroz-Telles… - Clinical microbiology …, 2008 - Am Soc Microbiol
Scedosporium spp. are increasingly recognized as causes of resistant life-threatening
infections in immunocompromised patients. Scedosporium spp. also cause a wide spectrum of …

Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses …

…, JR Perfect, Z Racil, E Roilides… - Clinical Infectious …, 2020 - academic.oup.com
Background Invasive fungal diseases (IFDs) remain important causes of morbidity and
mortality. The consensus definitions of the Infectious Diseases Group of the European …

[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

…, L Pagano, P Ribaud, M Richardson, E Roilides… - Clinical Microbiology …, 2018 - Elsevier
The European Society for Clinical Microbiology and Infectious Diseases, the European
Confederation of Medical Mycology and the European Respiratory Society Joint Clinical …

[HTML][HTML] Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey

…, S Messler, A Enimil, E Iosifidis, E Roilides… - The Lancet Global …, 2018 - thelancet.com
Background The Global Point Prevalence Survey (Global-PPS) established an international
network of hospitals to measure antimicrobial prescribing and resistance worldwide. We …

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a …

…, ÖK Azap, M Souli, E Roilides… - The Lancet Infectious …, 2017 - thelancet.com
Background The best available treatment against carbapenemase-producing
Enterobacteriaceae (CPE) is unknown. The objective of this study was to investigate the effect of …

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric …

…, JH Dalle, D Engelhard, W Hope, E Roilides… - The Lancet …, 2014 - thelancet.com
Invasive opportunistic fungal diseases (IFDs) are important causes of morbidity and mortality
in paediatric patients with cancer and those who have had an allogeneic haemopoietic stem…

Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in …

J Meletiadis, S Pournaras, E Roilides… - Antimicrobial agents …, 2010 - Am Soc Microbiol
The fractional inhibitory concentration (FIC) index range of 0.5 to 4 that is commonly used to
define additivity results in no interactions in most combination studies of antifungal agents. …

The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus …

…, M Mohammadi Ardehali, M Kord, E Roilides… - Mycoses, 2021 - Wiley Online Library
Acute respiratory distress syndrome is a common complication of severe viral pneumonia,
such as influenza and COVID‐19, that requires critical care including ventilatory support, use …